Company intelligence / Profile preview

ProSpine

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

ProSpine was a pioneering medical technology company focused on the development of artificial disc replacement systems for the spine. The company's flagship product, the ProDisc, was designed as an alternative to spinal fusion, allowing for the preservation of motion in patients with degenerative disc disease. ProSpine played a critical role in the clinical validation and commercialization of total disc replacement (TDR) technology. In 2003, the company was acquired by Synthes for $325 million, and its products continue to be marketed under the DePuy Synthes brand within Johnson & Johnson.

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on ProSpine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProSpine.

Explore the full profile